Aethlon Medical is a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. The Aethlon Hemopurifier (Hemopurifier) is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. We show 37 historical shares outstanding datapoints in our coverage of AEMD's shares outstanding history.
Understanding the changing numbers of AEMD shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AEMD versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AEMD by allowing them to research AEMD shares outstanding history
as well as any other stock in our coverage universe. |
Free AEMD Email Alerts:
Video: Shares Outstanding Importance
